{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:51:03Z","timestamp":1785711063302,"version":"3.56.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["23YF1458300"],"award-info":[{"award-number":["23YF1458300"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403789"],"award-info":[{"award-number":["82403789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nano.2026.102958","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:19:32Z","timestamp":1778825972000},"page":"102958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanotechnology mediated local interventions with systemic immunotherapy for hepatocellular carcinoma: Intelligent multimodal therapy"],"prefix":"10.1016","volume":"74","author":[{"given":"Qinghe","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102958_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.02.019","article-title":"Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)","author":"Bhoori","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.nano.2026.102958_bb0010","article-title":"KCTD1 stabilizes c-Myc to upregulate PD-L1 and suppress anti-tumor immunity in hepatocellular carcinoma","author":"Zhong","year":"2026","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.nano.2026.102958_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70059","article-title":"Global advances in hepatocellular carcinoma research and therapy in 2025","author":"Hu","year":"2026","journal-title":"Cancer Innov"},{"key":"10.1016\/j.nano.2026.102958_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103766","article-title":"Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study","author":"Chen","year":"2026","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.nano.2026.102958_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.01.012","article-title":"Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma: conversion surgery in HCC immunotherapy","author":"Xu","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.nano.2026.102958_bb0030","article-title":"New treatment options for MASLD patients with type 2 diabetes","author":"Mega","year":"2026","journal-title":"Life (Basel)"},{"key":"10.1016\/j.nano.2026.102958_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag054","article-title":"Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable HCC with PVTT following successful conversion therapy","author":"Wang","year":"2026","journal-title":"Oncologist"},{"key":"10.1016\/j.nano.2026.102958_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/hbsn-2025-98","article-title":"Continuation of first-line therapy with progression-directed local therapy: a potential 1.5-line strategy bridging the gap between first- and second-line systemic therapy in oligoprogressive hepatocellular carcinoma","author":"Zhang","year":"2026","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.nano.2026.102958_bb0045","doi-asserted-by":"crossref","first-page":"25536","DOI":"10.1021\/jacs.5c06039","article-title":"Engineered Nano-Micro Pyroptosis generators: a magnetic-Metallo-immunotherapeutic strategy to reinforce Transarterial embolization","volume":"147","author":"Wang","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2026.102958_bb0050","doi-asserted-by":"crossref","first-page":"39157","DOI":"10.1021\/acsnano.5c12168","article-title":"Magnetothermodynamic therapy enables selective elimination of Cancer cells in perivascular hepatocellular carcinoma","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0055","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1021\/acs.nanolett.4c01767","article-title":"A poly(amino acid)-based nanomedicine strategy: telomere-telomerase Axis targeting and magnetic resonance imaging in hepatocellular carcinoma treatment","volume":"24","author":"Zhang","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2026.102958_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.102210","article-title":"Phosphorus-32 microspheres: a dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and anti-PD1 immunotherapy potentiation","author":"Dai","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2026.102958_bb0065","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/acsnano.5c11352","article-title":"Stimuli-responsive nanozyme reprograms tumor immunometabolism and overcomes therapeutic resistance in hepatocellular carcinoma","volume":"20","author":"Ta","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0070","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/j.apsb.2025.08.003","article-title":"Arsenic trioxide-based nanoparticles for enhanced chemotherapy by activating pyroptosis","author":"Wang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2026.102958_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-026-04123-9","article-title":"Cell membranes-encapsulated gadolinium-doped carbon dots for the efficient photothermal and immunotherapeutic synergistic treatment of hepatocellular carcinoma","author":"Dong","year":"2026","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102958_bb0080","article-title":"Reducing postoperative recurrence of early-stage hepatocellular carcinoma by a wound-targeted nanodrug","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102958_bb0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jcis.2024.01.066","article-title":"Multifunctional metal-coordinated co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis","volume":"660","author":"Zhao","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2026.102958_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114694","article-title":"A hydrogen generator enhances immunogenic transarterial chemoembolization in hepatocellular carcinoma","volume":"392","author":"Cao","year":"2026","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102958_bb0095","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1021\/acsnano.5c19350","article-title":"Highly active strontium peroxide nanoparticles induce alkalization\/oxidation to potentiate Cancer Immuno-metabolic therapy","volume":"20","author":"Duan","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301352","article-title":"A sodium alginate-based multifunctional Nanoplatform for synergistic chemo-immunotherapy of hepatocellular carcinoma","volume":"35","author":"Huang","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102958_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymthe.2022.09.012","article-title":"Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma","volume":"31","author":"Liu","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2026.102958_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302013","article-title":"Size-tunable nanoregulator-based radiofrequency ablation suppresses MDSCs and their compensatory immune evasion in hepatocellular carcinoma","volume":"12","author":"Tang","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2026.102958_bb0115","doi-asserted-by":"crossref","first-page":"32818","DOI":"10.1021\/acsnano.4c11257","article-title":"Dual-synergistic Nanomodulator alleviates Exosomal PD-L1 expression enabling exhausted cytotoxic T lymphocytes rejuvenation for potentiated iRFA-treated hepatocellular carcinoma immunotherapy","volume":"18","author":"Zhu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8840","article-title":"A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management","volume":"10","author":"Sun","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2026.102958_bb0125","article-title":"Immunosuppressive microenvironment reprogramming by synergistic sonodynamic therapy of phthalocyanine-MOF hybrids for hepatocellular carcinoma","author":"Wu","year":"2026","journal-title":"exploration (Beijing)"},{"key":"10.1016\/j.nano.2026.102958_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2026.111384","article-title":"Development and validation of the APTNM staging system: integration of serum biomarkers with TNM classification for enhanced prognostic stratification following hepatectomy for hepatocellular carcinoma","volume":"52","author":"Li","year":"2026","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.nano.2026.102958_bb0135","doi-asserted-by":"crossref","DOI":"10.2147\/JHC.S570962","article-title":"Development of a nomogram model to predict post-transplant tumor recurrence in patients with hepatocellular carcinoma beyond the Milan Criteria undergoing TACE bridging therapy","author":"Wang","year":"2026","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.nano.2026.102958_bb0140","article-title":"p53 regulates glucose metabolic reprogramming in MASLD-related hepatocellular carcinoma via modulating mitochondrial pyruvate carriers","author":"Wang","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.nano.2026.102958_bb0145","doi-asserted-by":"crossref","first-page":"eadv2293","DOI":"10.1126\/scitranslmed.adv2293","article-title":"Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD","volume":"17","author":"Yu","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2026.102958_bb0150","article-title":"Transarterial chemoembolization combined with Camrelizumab and Rivoceranib for unresectable hepatocellular carcinoma (CHANCE2005\/CARES-005): a randomized phase II trial","author":"Zhu","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nano.2026.102958_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-026-11050-2","article-title":"Taiwan academy of tumor ablation (TATA) consensus on hepatocellular carcinoma ablation","author":"Chang","year":"2026","journal-title":"Hepatol Int"},{"key":"10.1016\/j.nano.2026.102958_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116593","article-title":"Tailored proton beam therapy for hepatocellular carcinoma: addressing unmet needs through a multidisciplinary approach","volume":"237","author":"Lee","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nano.2026.102958_bb0165","doi-asserted-by":"crossref","first-page":"eadv0885","DOI":"10.1126\/sciadv.adv0885","article-title":"Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: from animal models to a pilot clinical study","volume":"11","author":"Gong","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2026.102958_bb0170","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Arginine-loaded nano-calcium-phosphate-stabilized Lipiodol pickering emulsions potentiates transarterial embolization-immunotherapy","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102958_bb0175","article-title":"Cholesterol targeted catalytic hydrogel fueled by tumor debris can enhance microwave ablation therapy and anti-tumor immune response","author":"Shen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102958_bb0180","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.apsb.2025.03.015","article-title":"Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma","author":"Wang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2026.102958_bb0185","doi-asserted-by":"crossref","first-page":"34659","DOI":"10.1021\/acsnano.5c08326","article-title":"Fluorinated proteolysis targeting chimeras-Sorafenib Nanoassembly for epigenetic remodeling to combat multi-pathway drug resistance in hepatocellular carcinoma","volume":"19","author":"Lin","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0190","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/acs.nanolett.4c05798","article-title":"Promising nanoparticles-based Oral therapy for effective inhibition of hepatocellular carcinoma with portal vein tumor Thrombus","volume":"25","author":"Chen","year":"2025","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2026.102958_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12951-025-03440-9","article-title":"Tumor-microenvironment responsive nanomodulator for near infrared photothermal immunotherapy of hepatocellular carcinoma","author":"Kong","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102958_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1217748","article-title":"Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis","volume":"10","author":"Munoz-Bravo","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nano.2026.102958_bb0205","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jtho.2021.03.027","article-title":"Phase 3 trial comparing nanoparticle albumin-bound paclitaxel with docetaxel for previously treated advanced NSCLC","volume":"16","author":"Yoneshima","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.nano.2026.102958_bb0210","article-title":"FlexiPlasma microcatheter-embolic material (FPM-EM) platform: a non-inflammatory Pyroptosis strategy for precision hepatocellular carcinoma therapy","volume":"9","author":"Li","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.nano.2026.102958_bb0215","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1021\/acsnano.5c12430","article-title":"NIR-II multimodal Phototheranostics synergized with antigen-specific vaccines for boosted Cancer Photoimmunotherapy","volume":"20","author":"Yang","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0220","doi-asserted-by":"crossref","first-page":"35385","DOI":"10.1021\/acsnano.5c06278","article-title":"Virus-like particle-based personalized Neoantigen Nano-vaccine for tumor immunotherapy and recurrence prevention","volume":"19","author":"Zhou","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0225","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1166\/jnn.2021.18894","article-title":"Molybdenum dioxide (MoS(2))\/gadolinium (Gd) containing arginine-Glycine-aspartic acid (RGD) sequences as new Nano-contrast agent for Cancer magnetic resonance imaging (MRI)","volume":"21","author":"Hao","year":"2021","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2026.102958_bb0230","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Arginine-loaded Nano-calcium-phosphate-stabilized Lipiodol Pickering emulsions potentiates Transarterial embolization-immunotherapy","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102958_bb0235","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","author":"Dong","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2026.102958_bb0240","article-title":"Cholesterol targeted catalytic hydrogel fueled by tumor debris can enhance microwave ablation therapy and anti-tumor immune response","volume":"12","author":"Shen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102958_bb0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12951-025-03440-9","article-title":"Tumor-microenvironment responsive nanomodulator for near infrared photothermal immunotherapy of hepatocellular carcinoma","volume":"23","author":"Kong","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102958_bb0250","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/02656736.2022.2093413","article-title":"Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness","volume":"39","author":"Huang","year":"2022","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.nano.2026.102958_bb0255","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00270-022-03117-y","article-title":"Percutaneous thermal segmentectomy: proof of concept","author":"Lucatelli","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.nano.2026.102958_bb0260","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/08853282251374426","article-title":"Novel dual-targeted modified polyester albumin nano-carriers enhance the efficacy of hepatocellular carcinoma outcomes after encapsulating lenvatinib","volume":"40","author":"Jiang","year":"2026","journal-title":"J Biomater Appl"},{"key":"10.1016\/j.nano.2026.102958_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202414365","article-title":"Enhancing radiofrequency ablation for hepatocellular carcinoma: Nano-Epidrug effects on immune modulation and antigenicity restoration","volume":"36","author":"Li","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102958_bb0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00262-025-04286-8","article-title":"Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors","author":"Yang","year":"2026","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2026.102958_bb0275","article-title":"Activated ATF6alpha is a hepatic tumour driver restricting immunosurveillance","author":"Li","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.nano.2026.102958_bb0280","article-title":"Tumor-associated CD19(+) macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma","author":"Wang","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102958_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114695","article-title":"Dual-payload small-molecule drug conjugates enable bystander anticancer activity with reduced nonspecific release","volume":"392","author":"Chen","year":"2026","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102958_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202505833","article-title":"Hypoxia-activated Imidazoquinoline prodrug nanoparticles potentiate radiofrequency ablation-mediated antitumor immunity against hepatocellular carcinoma","volume":"21","author":"Ji","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.nano.2026.102958_bb0295","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ae1c09","article-title":"Surface-engineering RNA nanoparticles for targeted and efficient hepatocellular carcinoma drug delivery","volume":"20","author":"Youn","year":"2025","journal-title":"Biomed Mater"},{"key":"10.1016\/j.nano.2026.102958_bb0300","article-title":"Phosphorus-32 microspheres: a dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and anti-PD1 immunotherapy potentiation","volume":"34","author":"Dai","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2026.102958_bb0305","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.apsb.2025.03.015","article-title":"Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2026.102958_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.139050","article-title":"In situ generation of hydroperoxide-rich-peptide-based nano-assemblies for self-amplified magnetic resonance imaging-guided synergistic tumor chemo\/chemodynamic\/ferroptotic therapy","volume":"703","author":"Cheng","year":"2026","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2026.102958_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117697","article-title":"DNA triangular prism nanostructure and CRISPR\/Cas12a empowered electrochemical biosensor for dual detection of alpha-fetoprotein and microRNA 122","volume":"287","author":"Zhang","year":"2025","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.nano.2026.102958_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202519473","article-title":"Optimized lipid nanoparticles for co-delivery of mRNA and siRNA therapeutics in refractory liver Cancer","volume":"38","author":"Liao","year":"2026","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102958_bb0325","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery. In","author":"Cullis","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2026.102958_bb0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404555121","article-title":"Toward understanding lipid reorganization in RNA lipid nanoparticles in acidic environments","author":"Garaizar","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nano.2026.102958_bb0335","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.1021\/acsnano.4c00063","article-title":"Delivery of mRNA encoding Interleukin-12 and a stimulator of interferon genes agonist potentiates antitumor efficacy through reversing T cell exhaustion","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/polym17070955","article-title":"Chitosan-folic acid-coated quercetin-loaded PLGA nanoparticles for hepatic carcinoma treatment","author":"Kumar Sahdev","year":"2025","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.nano.2026.102958_bb0345","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1039\/D3NR01548C","article-title":"A drug co-delivery platform made of magnesium-based micromotors enhances combination therapy for hepatoma carcinoma cells","volume":"15","author":"Song","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.102958_bb0350","doi-asserted-by":"crossref","first-page":"46492","DOI":"10.1021\/acsomega.4c08010","article-title":"Multi-omics insights into PDHA1 as a predictive biomarker for prognosis, immunotherapy efficacy, and drug sensitivity in hepatocellular carcinoma","volume":"9","author":"Pan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.nano.2026.102958_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27020775","article-title":"Antitumor evaluation of Rhenium-188 and paclitaxel co-delivered via thermosensitive hydrogel in a hepatocellular carcinoma animal model","author":"Shih","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102958_bb0360","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj7540","article-title":"Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence","author":"Sunassee","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2026.102958_bb0365","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242315","article-title":"Idarubicin versus epirubicin in transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: An open-label, randomized, Phase IV trial","volume":"315","author":"Liu","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2026.102958_bb0370","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21037\/hbsn-2025-507","article-title":"Anthracycline selection in drug-eluting-beads-transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma: emerging evidence for idarubicin","author":"Makary","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.nano.2026.102958_bb0375","article-title":"Reverse lipid droplet function for hepatocellular carcinoma immunotherapy","volume":"65","author":"Cai","year":"2026","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.nano.2026.102958_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/biom16020329","article-title":"Targeting fatty acids in liver cancer: molecular insights and drug approaches","author":"Cigliano","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.nano.2026.102958_bb0385","article-title":"CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist","volume":"7","author":"Liu","year":"2026","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.nano.2026.102958_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12951-025-03992-w","article-title":"Sorafenib nanomedicine in HCC: nano-bio interactions and combination therapies. In","author":"Lu","year":"2026","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102958_bb0395","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.2147\/IJN.S518120","article-title":"ROS-responsive nanosystem targeted co-delivery YC-1 and Regorafenib to alleviate hypoxia enhancing hepatocellular carcinoma therapy","author":"Song","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102958_bb0400","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/acs.nanolett.5c05256","article-title":"HepatoAI(LFA): machine-learning-assisted Nano-enhanced point-of-care system for personalized precise diagnosis of hepatocellular carcinoma","volume":"26","author":"Zuo","year":"2026","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2026.102958_bb0405","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70574","article-title":"Sex differences in liver Cancer mortality trends in the US: role of Cancer type, Aetiology, and birth cohort","volume":"46","author":"Fedeli","year":"2026","journal-title":"Liver Int"},{"key":"10.1016\/j.nano.2026.102958_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmogo.2025.100186","article-title":"Early Bevacizumab dose and time modifications may affect efficacy of Atezolizumab plus Bevacizumab for advanced hepatocellular carcinoma treatment","author":"Rossari","year":"2025","journal-title":"ESMO Gastrointest Oncol"},{"key":"10.1016\/j.nano.2026.102958_bb0415","article-title":"Bibliometric analysis of application of radiomics and artificial intelligence integration in personalized treatment of hepatocellular carcinoma","author":"Yu","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.nano.2026.102958_bb0420","doi-asserted-by":"crossref","first-page":"eadv0885","DOI":"10.1126\/sciadv.adv0885","article-title":"Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: from animal models to a pilot clinical study","author":"Gong","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2026.102958_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146571","article-title":"Differences in tissue copper and zinc content between normal livers and those with cirrhosis with or without hepatocellular carcinoma","author":"Parisse","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102958_bb0430","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/01635581.2024.2415136","article-title":"Alterations of nutrient elements in hepatocellular carcinoma patients treated with Atezolizumab-bevacizumab","volume":"77","author":"Xiao","year":"2025","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.nano.2026.102958_bb0435","article-title":"Multi-omics analysis of NEDD1 in hepatocellular carcinoma: biological function, prognostic value, and clinical significance","author":"Chen","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102958_bb0440","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000915","article-title":"Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification","author":"Tseng","year":"2026","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.nano.2026.102958_bb0445","article-title":"Extracellular vesicles in liver fibrosis: pathogenic messengers, diagnostic biomarkers, and therapeutic nanovectors","author":"Zhao","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102958_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18040627","article-title":"Immunotherapy in hepatocellular carcinoma with portal vein tumour thrombosis: from poor prognosis to curative-intent strategies","author":"Marzi","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nano.2026.102958_bb0455","author":"Uschner","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.nano.2026.102958_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.02.027","article-title":"BCLC classification and AI-based image quantification: what is meant to be will come together - but how and when?: BCLC and AI-based image quantification","author":"Muller","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.nano.2026.102958_bb0465","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001733","article-title":"The role of OSM\/OSMRbeta axis in shaping the tumor microenvironment favouring MASLD-related HCC immune evasion","author":"Nurcis","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.nano.2026.102958_bb0470","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1021\/acsnano.3c08064","article-title":"A booster for radiofrequency ablation: advanced adjuvant therapy via in situ Nanovaccine synergized with anti-programmed death ligand 1 immunotherapy for systemically constraining hepatocellular carcinoma","volume":"17","author":"Tian","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102958_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122766","article-title":"Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy","volume":"313","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2026.102958_bb0480","article-title":"DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma","volume":"218395","author":"Gao","year":"2026","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2026.102958_bb0485","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-026-11067-7","article-title":"ZG16 represses tumor progression and M2 polarization of tumor-associated macrophages in hepatocellular carcinoma by promoting ubiquitination and degradation of SNX9 via binding to ITCH","author":"Meng","year":"2026","journal-title":"In Hepatol Int"},{"key":"10.1016\/j.nano.2026.102958_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116581","article-title":"Impact of gut microbiota on hepatocellular carcinoma: pathogenesis, diagnosis, prognosis, and therapeutic prospective","volume":"237","author":"Chen","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nano.2026.102958_bb0495","article-title":"The molecular network of neutrophil extracellular traps in hepatocellular carcinoma: biogenesis, function, and therapeutic implications","author":"Liu","year":"2026","journal-title":"In Molecules"},{"key":"10.1016\/j.nano.2026.102958_bb0500","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1021\/acsomega.5c11091","article-title":"Harnessing Anoikis-related gene signatures for immunotherapy precision: a machine learning-driven predictive and prognostic model","volume":"11","author":"Wang","year":"2026","journal-title":"ACS Omega"},{"key":"10.1016\/j.nano.2026.102958_bb0505","series-title":"Radiomics Predicts Poorly Differentiated Hepatocellular Carcinoma and Uncovers Ribosomal-Immune Dysregulation Mechanism","author":"Gao","year":"2026"},{"key":"10.1016\/j.nano.2026.102958_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.01.021","article-title":"Detection of esophageal varices and prediction of hepatic decompensation in Unresectable hepatocellular carcinoma using AI: AI detection of varices and decompensation","author":"Rabasco Meneghetti","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.nano.2026.102958_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.01.015","article-title":"Serum procalcitonin: a novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma","author":"Nault","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.nano.2026.102958_bb0520","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000902","article-title":"Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis","author":"Singal","year":"2026","journal-title":"In Hepatol Commun"},{"key":"10.1016\/j.nano.2026.102958_bb0525","doi-asserted-by":"crossref","DOI":"10.1159\/000550100","article-title":"Utility of biomarker panels in the surveillance and monitoring of hepatocellular carcinoma: consensus statements from an international Delphi panel","author":"Singal","year":"2025","journal-title":"In Liver Cancer"},{"key":"10.1016\/j.nano.2026.102958_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120805","article-title":"Next-generation nano-biosensors for hepatocellular carcinoma","volume":"582","author":"Abuhassan","year":"2026","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nano.2026.102958_bb0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41575-024-01024-w","article-title":"Precision models in hepatocellular carcinoma","author":"Barcena-Varela","year":"2025","journal-title":"In Nat Rev Gastroenterol Hepatol, pp"},{"key":"10.1016\/j.nano.2026.102958_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18040609","article-title":"Advances in the therapeutic landscape of hepatocellular carcinoma: current strategies and future perspectives","author":"Morishita","year":"2026","journal-title":"In Cancers (Basel)"},{"key":"10.1016\/j.nano.2026.102958_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105879","article-title":"Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis","volume":"10","author":"Salani","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.nano.2026.102958_bb0550","series-title":"Novel Long-Read Sequencing Method for Characterisation of Hepatitis B Transcripts Show High Expression of Chimeric HBV\/Human RNA","first-page":"e70521","author":"Stenback","year":"2026"},{"key":"10.1016\/j.nano.2026.102958_bb0555","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/hepr.70130","article-title":"Recent advances in liver computed tomography and magnetic resonance imaging technologies","volume":"56","author":"Tanabe","year":"2026","journal-title":"Hepatol Res"},{"key":"10.1016\/j.nano.2026.102958_bb0560","article-title":"Next-generation flexible embolic systems: targeted transarterial chemoembolization strategies for hepatocellular carcinoma","volume":"37","author":"Wu","year":"2025","journal-title":"Adv Mater"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:25:50Z","timestamp":1785709550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":112,"alternative-id":["S1549963426000596"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102958","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology mediated local interventions with systemic immunotherapy for hepatocellular carcinoma: Intelligent multimodal therapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102958"}}